BioSpace News Archive

Dr. Gregory Jantz, best-selling author of 40 books, founder of nationally acclaimed The Center • A Place of HOPE in Edmonds, Washington, and leading mental health expert, announced today that he is providing free copies of his most recent books for those struggling with depression and anxiety.

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that David Meline has joined Moderna as Chief Financial Officer, effective Monday, June 8, 2020.

Streamline Health Solutions, Inc. (NASDAQ:STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises today announced that it will release its first quarter 2020 financial performance for the period that ended April 30, 2020, on Wednesday, June 10, 2020 after the close of the financial markets. The Company will conduct a conference call to review the resu

Massachusetts Company Repurposes Capabilities to Package 3D-Printed Nasal Swabs For COVID-19 Testing and Seeks to Hire Additional Workers as Production Ramps Up

Jupiter Medical Center, the number one ranked hospital for safety, quality and patient satisfaction in Palm Beach County and the Treasure Coast region, today announced the appointment of Charles Murphy, Jr., MD, CPPS as Chief Quality and Patient Safety Officer.

Alcami, a United States -based contract development and manufacturing organization (CDMO), announced today the appointment of Walter J. Kaczmarek III as Chief Executive Officer. Mr. Kaczmarek, who has over 30 years of experience in the pharmaceutical industry, will focus on advancing Alcami’s next phase of strategic growth.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new long-term results showing that once daily upadacitinib continued to improve signs and symptoms in patients with rheumatoid arthritis at 72 and 84 weeks in the SELECT-COMPARE (upadacitinib, 15 mg in combination with methotrexate [MTX]) and SELECT-MONOTHERAPY

ATC Alert LLC, a leading Connected Health company, today announced the completion of its acquisition of East Rock Medical Alert’s PERS accounts.

VBL Therapeutics, announced new data implicating the potential of its proprietary anti-MOSPD2 antibodies for treatment of rheumatoid arthritis.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 1:20 p.m. ET.